Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership37,584 shares
Latest Disclosed Value $ 4,950,661
Captrust Financial Advisors reports 21.52% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 37,584 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $4,950,661 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 30,928 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 21.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 37,584 6,656 21.52 4,951 12.86 0.0085
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 30,928 2,877 10.26 4,387 11.40 0.0083
2025-11-19 2025-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 28,051 15,875 130.38 3,938 157.32 0.0080
2025-08-15 2025-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 12,176 4,866 66.57 1,530 89.36 0.0034
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 7,310 -4,334 -37.22 808 -49.15 0.0020
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 11,644 1,836 18.72 1,589 40.62 0.0045
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 9,808 52 0.53 1,130 -15.86 0.0034
2024-08-15 2024-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 9,756 1,598 19.59 1,343 19.38 0.0043
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 8,158 -3,673 -31.05 1,125 -27.79 0.0041
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 11,831 8,355 240.36 1,559 298.47 0.0054
2023-11-15 2023-09-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 3,476 493 16.53 391 39.15 0.0015
2023-08-15 2023-06-30 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 2,983 100 3.47 281 -3.44 0.0011
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 2,883 -63 -2.14 292 -17.09 0.0013
2023-02-15 2022-12-31 13F NEUROCRINE BIOSCIENCES INC COM Stock 64125C109 2,946 1,017 52.72 352 71.22 0.0018
2022-11-16 2022-09-30 13F NEUROCRINE BIOSCIENCES INC COM CEF 64125C109 1,929 265 15.93 205 26.54 0.0012
2022-08-23 2022-06-30 13F/A-1 NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 1,664 270 19.37 162 23.66 0.0010
2022-08-16 2022-06-30 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 1,828 434 178 0.0013
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,394 -105 -7.00 131 2.34 0.0008
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 1,499 232 18.31 128 4.92 0.0009
2021-11-16 2021-09-30 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 1,267 31 2.51 122 1.67 0.0010
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 1,236 205 19.88 120 20.00 0.0011
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 1,031 1,031 100 0.0011
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 0 -107 -100.00 0 -100.00
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 107 0 0.00 10 11.11 0.0004
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 107 0 0.00 9 0.00 0.0003
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 107 107 9 0.0004
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 0 -154 -100.00 0 -100.00
2018-11-15 2018-09-30 13F NEUROCRINE BIOSCIENCES INC COM Common Stock 64125C109 154 154 19 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.